Last, integration of screening for TB infection (risk factor review and serum interferon gamma release assays testing) with community COVID-19 prevention efforts among subpopulations with shared risk profiles, as has been done for persons at increased risk for COVID-19 and diabetes (21), may expand high-yield opportunities to prevent TB. The gene discussed is IFNG; the disease is COVID-19.